Insider insights – Q&A with Tom Holmes of Amylyx Pharmaceuticals


When two young innovators, Justin Klee and Joshua Cohen, Co-Founders and Co-CEOs of Amylyx Pharmaceuticals, discovered a potentially life-changing molecule in their dorm room at Brown University, they embarked on a journey to clinical trials to help treat people living with ALS. Amylyx’ Global Head of Supply Chain, Tom Holmes, shares more about their experience teaming up with Thermo Fisher Scientific to manufacture their product.